We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
2276
Tvardi Therapeutics
TVRD
$23.7M
$93K ﹤0.01%
212
-285
-57% -$143K
BFX
2277
DELISTED
BowFlex Inc.
BFX
$93K ﹤0.01%
15,205
+4,655
+44% +$38.6K
BRG
2278
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$93K ﹤0.01%
3,511
-200
-5% -$3.17K
ALXO icon
2279
ALX Oncology
ALXO
$271M
$92K ﹤0.01%
4,277
+2,852
+200% +$123K
BGFV
2280
DELISTED
Big 5 Sporting Goods
BGFV
$92K ﹤0.01%
4,835
-10,844
-69% -$271K
CERS icon
2281
Cerus
CERS
$601M
$92K ﹤0.01%
13,535
-31,131
-70% -$210K
CNQ icon
2282
Canadian Natural Resources
CNQ
$98.9B
$92K ﹤0.01%
4,462
-13,520
-75% -$274K
FTI icon
2283
TechnipFMC
FTI
$30.8B
$92K ﹤0.01%
15,522
-6,421
-29% -$44.1K
NCTY
2284
The9 Ltd
NCTY
$70M
$92K ﹤0.01%
1,362
+848
+165% +$86.1K
RUBY
2285
DELISTED
Rubius Therapeutics, Inc
RUBY
$92K ﹤0.01%
9,417
-88
-0.9% -$1.22K
ALHC icon
2286
Alignment Healthcare
ALHC
$2.9B
$91K ﹤0.01%
6,491
+2,306
+55% +$40.4K
CNX icon
2287
CNX Resources
CNX
$5.28B
$91K ﹤0.01%
6,639
-30,178
-82% -$425K
CUBI icon
2288
Customers Bancorp
CUBI
$2.82B
$91K ﹤0.01%
1,394
-1,892
-58% -$104K
EC icon
2289
Ecopetrol
EC
$35.3B
$91K ﹤0.01%
+7,018
New +$100K
MBWM icon
2290
Mercantile Bank Corp
MBWM
$1.06B
$91K ﹤0.01%
2,608
+1,926
+282% +$67.1K
PAC icon
2291
Grupo Aeroportuario del Pacifico
PAC
$12.3B
$91K ﹤0.01%
+663
New +$84.8K
TECK icon
2292
Teck Resources
TECK
$31.2B
$91K ﹤0.01%
3,159
-3,534
-53% -$97K
VBIV
2293
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$91K ﹤0.01%
1,294
+263
+26% +$22.2K
ATKR icon
2294
Atkore
ATKR
$3.17B
$90K ﹤0.01%
814
-4,148
-84% -$421K
CGEM icon
2295
Cullinan Oncology
CGEM
$1.31B
$90K ﹤0.01%
5,846
+5,107
+691% +$102K
CM icon
2296
Canadian Imperial Bank of Commerce
CM
$113B
$90K ﹤0.01%
1,548
-6,504
-81% -$379K
ECAT icon
2297
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.54B
$90K ﹤0.01%
+4,849
New +$93.8K
IRTC icon
2298
iRhythm Holdings
IRTC
$4.17B
$90K ﹤0.01%
767
-906
-54% -$83.1K
NOVT icon
2299
Novanta
NOVT
$6.3B
$90K ﹤0.01%
511
-355
-41% -$59.3K
RBC icon
2300
RBC Bearings
RBC
$17.7B
$90K ﹤0.01%
442
-452
-51% -$97.1K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.